Madhav Seshadri, MD

Education
2022 - Chief Fellow, Hematology and Oncology, New York-Presbyterian Hospital, Weill Cornell Medical Center
2022 - Fellowship, Hematology and Oncology, New York-Presbyterian Hospital, Weill Cornell Medical Center
2019 - Residency, Internal Medicine, New York-Presbyterian Hospital, Weill Cornell Medical Center
MD, 2016 - , Emory University School of Medicine
BA, 2009 - Neuroscience, Johns Hopkins University
Honors and Awards
  • Research Training Award for Fellows, American Society of Hematology, 2021-2022
  • Abstract Achievement Award, American Society of Hematology, 2021
  • Ann Hoyt Jolley Merit Scholarship, Emory University School of Medicine, 2015-2016
Publications

  1. Oluwole OO, Crofford L, Jallouk AP, Lee DW, Gardner R, Piquet AL, Jackson SW, Velarde AM, Meyer E, Knight TE, Seshadri MR, Mirza S, Wacker K, Wilfong E. Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Transplantation and cellular therapy 2026. PMID: 42134594


  2. Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). Journal of the National Comprehensive Cancer Network : JNCCN 2026. PMID: 41921576


  3. Bowers JT, Vijayanarayanan A, Gill N, Traglia M, Thomas R, Andreadis CB, Ai WZ, Ho C, Kaplan LD, Merrill MH, Seshadri MR, Randall MP, Rubenstein JL, Ganapathi K, Prakash S, Devine WP, Spinner MA. CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS). Journal of the National Comprehensive Cancer Network : JNCCN 2026. PMID: 41991041


  4. Gyawali B, Bohlke K, Dickter JK, Kelkar AH, Knopf KB, Rapoport BL, Roof L, Schott S, Seshadri MR, Shilpakar R, Smith TJ, Trapani D, Woodard AB, Cigler T. WBC Growth Factors: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2026. PMID: 41740078


  5. Tolu SS, Gribbin C, Chen Z, Seshadri MR, Orlando E, Grenet J, Toor R, Sanjurjo A, Cherng HJ, Sawas A, Phillips A, Shore T, Martin P, Leonard JP, Inghirami G, van Besien K, Pro B, Amengual JE, Ruan J. Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents. Leukemia & lymphoma 2025. PMID: 40811484


  6. Thiruvengadam SK, Merryman R, Wang Y, Gaulin C, Bezerra E, Voorhees T, Seshadri MR, Falade A, Habib A, Ayers AA, Bailey M, Brown A, Bailey N, Patel K, Andreadis CB, Kittai AS, Jacobson C, Palmer J, Forman SJ, Nastoupil L, Budde LE. Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma. American journal of hematology 2024. PMID: 39715004


  7. Barrios JP, Seshadri MR, Tison GH. Artificial Intelligence to Complement, Not Replace, Clinical Knowledge: Reading Between the Lines. JACC. CardioOncology 2024. PMID: 38774016


  8. Banerjee R, Wang V, Huang CY, Pandita D, Leonard MK, LaRue S, Ahmadi M, Kaplan L, Ai WZ, Fakhri B, Spinner M, Seshadri MR, Pampaloni MH, Andreadis CB. Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy. European journal of nuclear medicine and molecular imaging 2023. PMID: 37300573


  9. Laurence J, Nuovo G, Racine-Brzostek SE, Seshadri M, Elhadad S, Crowson AN, Mulvey JJ, Harp J, Ahamed J, Magro C. Premortem Skin Biopsy Assessing Microthrombi, Interferon Type I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage. The American journal of pathology 2022. PMID: 35640675


  10. Seshadri M, Crane GM, Gergis U. Ofatumumab for Post-Transplant Lymphoproliferative Disorder. Hematology/oncology and stem cell therapy 2022. PMID: 32413419


  11. Seshadri MR, Melnick AM. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. Leukemia & lymphoma 2021. PMID: 34783281


  13. Laurence J, Mulvey JJ, Seshadri M, Racanelli A, Harp J, Schenck EJ, Zappetti D, Horn EM, Magro CM. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clinical immunology (Orlando, Fla.) 2020. PMID: 32771488


  14. Seshadri M, Qu CK. Microenvironmental regulation of hematopoietic stem cells and its implications in leukemogenesis. Current opinion in hematology 2016. PMID: 27071022


  15. Attaluri A, Seshadri M, Mirpour S, Wabler M, Marinho T, Furqan M, Zhou H, De Paoli S, Gruettner C, Gilson W, DeWeese T, Garcia M, Ivkov R, Liapi E. Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2016. PMID: 27151045


  16. Song WJ, Seshadri M, Ashraf U, Mdluli T, Mondal P, Keil M, Azevedo M, Kirschner LS, Stratakis CA, Hussain MA. Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell metabolism 2011. PMID: 21356520